Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

600.42 +38.15 (+6.78%)
Streaming Delayed Price Updated: 3:29 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,638,940
Open 570.87
Bid (Size) 600.09 (3)
Ask (Size) 600.74 (1)
Prev. Close 562.27
Today's Range 569.99 - 615.39
52wk Range 476.49 - 1,061.60
Shares Outstanding 91,779,465
Dividend Yield 0.29%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wednesday's session: top gainers and losers in the S&P500 index
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday. 
Via Chartmill
Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?
Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat. 
Via Benzinga

Performance

YTD
-16.0%
-16.0%
1 Month
+3.9%
+3.9%
3 Month
+12.2%
+12.2%
6 Month
-2.7%
-2.7%
1 Year
-42.9%
-42.9%

More News

Read More
Which S&P500 stocks are moving on Wednesday?
Via Chartmill
Nvidia, Amphenol, Lockheed Martin And A Health Care Stock On CNBC's 'Final Trades'
Via Benzinga
Topics Artificial Intelligence
Acuity, Lithium Americas, Rezolve AI, AES And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Artificial Intelligence
Regeneron to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on October 28, 2025
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
2 Beaten-Down Stocks to Buy and Hold for a Decade
Via The Motley Fool
Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes
Via MarketMinute
1 Healthcare Stock with Exciting Potential and 2 We Ignore
Via StockStory
Topics Stocks
FDA Expands Use Of Regeneron's Evkeeza To Infants With Rare Cholesterol Disorder
Via Benzinga
Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Why Regeneron (REGN) Shares Are Falling Today
Via StockStory
Eli Lilly Ends Bimagrumab Obesity Study Weeks After Launch
Via Benzinga
1 Safe-and-Steady Stock on Our Watchlist and 2 We Question
Via StockStory
What Does the Market Think About Regeneron Pharmaceuticals?
Via Benzinga
Why Regeneron (REGN) Stock Is Down Today
Via StockStory
Wall Street Pauses For A Breather, Small Caps Soar: What's Moving Markets Tuesday?
Via Benzinga
Discover which S&P500 stocks are making waves on Tuesday.
Via Chartmill
Scholar Rock's Spinal Muscular Atrophy Drug Faces FDA Delay Over Catalent Indiana Inspection
Via Benzinga
Tuesday's session: gap up and gap down stock in the S&P500 index
Via Chartmill
1 S&P 500 Stock on Our Buy List and 2 We Turn Down
Via StockStory
Topics Stocks
FDA Delays Key Sanofi Multiple Sclerosis Drug Decision
Via Benzinga
Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
REGENERON PHARMACEUTICALS (NASDAQ:REGN) Screens as a Top Value Stock with Strong Fundamentals
Via Chartmill
Can Regeneron Change The Paradigm In Multiple Myeloma — And Undercut J&J?
Via Investor's Business Daily

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 600.42
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 10/01/25 03:29 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 55.11B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 55B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.